| [1］ 杨孜．生物学标记结合临床风险推动子痫前期预测更上一层楼[J]. 中华围产医学杂志, 2011，7: 385-389． [2］ Myatt L, Rebecca G,Clifton, et al. First-trimester prediction of preeclampsia in low-risk nulliparous women[J]. Obstet Gynecol, 2012，119(6): 1234-1242. [3］ Loire P,Vicaut E,Cruaud P, et al.Limited value of angiogenic factors in obese women[M].Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health,2012:2368-2370. [4］ Ghosh SK,Raheja S,Tuli A, et al. Serum placental growth factor as a predictor of early onset preeclampsia in overweight/obese pregnant women[J]. J Am Soc Hypertens, 2013,7(2):137-148. [5］ 杨孜.早发型重度先兆子痫-产科医师面临的挑战[J].中国妇产科临床,2003, 4(2) :83-89. [6］ 杨孜，王伽略，黄萍，等．重度子痫前期终末器官受累不平行性和围产结局探讨[J]．中华围产医学杂志，2006，9：10-14． [7］ 杨孜，李蓉，石凌懿，等．早发型重度先兆子痫的临床界定及保守治疗探讨[J]．中华妇产科杂志，2005，40：302-305． [8］ Ma RQ，Sun MN，Yang Z．Effects of preeclampsia-like symptoms at early gestational stage on feto-placental outcomes in a mouse model[J]. Chin Med J ( Engl), 2010, 123( 6) : 707-712. [9］ Theobald GW, Camb MD. Effect of calcium and vitamins a and d on incidence of pregnancy toxaemia[J]. Lancet, 1937,2:1397-1399. [10］ Magee LA，Helewa M，Moutquin JM，et al．Diagnosis，evaluation，and management of the hypertensive disorders of pregnancy［J］．J Obstet Gynaecol Can，2008,30:S1-48． [11］ Visintin C， Mugglestone MA， Almerie MQ， et al．Management of hypertensive disorders during pregnancy：summary of NICE guidance[J]．BMJ，2010，340：c2207． [12］ Coomarasamy A，Honest H，Papaioannou S，et al．Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review[J]. Obstet Gynecol, 2003,101:1319-1332. [13］ Askie LM，Duley L，Henderson-Smart DJ， et al． Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data[J].Lancet,2007,369: 1791-1798. [14］ Bujold E，Roberge S，Lacasse Y，et al．Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy：a meta-analysis[J]．Obstet Gynecol，2010，116：402-414． [15］ Lowe S，Brown M，Dekker G，et al．Guidelines for the management of hypertensive disorders of pregnancy:australia and new Zealand[J]．Aust U Z J Obstet Gyneacol，2009，49：242-246． [16］ Poston L, Briley AL, Seed PT, et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial[J]. Lancet,2006,367:1145-1154. [17］ Brion LP, Bell EF, Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants[J]. Cochrane Database of Syst Rev, 2003, 3: CD003665. [18］ 任淑萍，牛姝，吕乐,等. 过量维生素Ｅ摄入对大鼠脂代谢的影响[J].吉林大学学报（医学版）,2011,37:61-63. [19］ Chappell LC, Seed PT, Briley AL, et al.Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial[J]. Lancet,1999,354:810-816. [20］ Vadillo-Ortega F, Perichart-Perera O, Espino S, et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled tria[J]. BMJ, 2011,342:d2901. [21］ Costantine MM, Cleary K. Eunice kennedy shriver national institute of child health and human development obstetric--fetal pharmacology research units network:pravastatin for the prevention of preeclampsia in high-risk pregnant women[J]. Obstet Gynecol,2013,121:349-353. [22］ Cindrova-Davies T, Herrera EA, Niu Y,et al. Reduced cystathionine γ-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator[J]. Am J Pathol, 2013,182: 1448-1458. [23］ Bertoia ML, Waring ME, Gupta PS, et al. Implications of new hypertension guidelines in the United States[J]. Hypertension,2012,60:639-644. [24］ 史峻梅，杨孜，陈蕾，等．重度子痫前期患者临床发病前预警信息分析[J]．中华妇产科杂志，2009，44：337-340． [25］ 史峻梅，杨孜，陈蕾，等．重度子痫前期临床警示因素与产前随访时限[J]．中国妇幼保健，2009，24：2768-2771． [26］ 黄萍, 杨孜, 张 坤,等. 重度子痫前期191例严重并发症的监测[J].中国实用妇科与产科杂志,2006,22:828-831. |
